⌘K
Loading ticker…
As of 2026-08-24, Mirum Pharmaceuticals, Inc. Common Stock (MIRM) has a 3-month relative strength percentile of 44 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 53. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.2%, relative volume 0.51×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
MIRM appears in 1 ETF as of Jun 2026: PSC at 0.30% weight, $7M notional.
Held by 73 ETFs · $715M across latest filings · largest weight 4.92% (LFSC).
Top 1 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| PSC | 0.30% | $7M | +0.02 pp |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MIRM Jan avg: 14.73% median: 19.31% win: 75% σ: 17.59% n: 4 2022-04-12 → 2026-07-31 | MIRM Feb avg: -1.16% median: -1.28% win: 50% σ: 7.88% n: 4 2022-04-12 → 2026-07-31 | MIRM Mar avg: -3.88% median: -2.60% win: 50% σ: 6.55% n: 4 2022-04-12 → 2026-07-31 | MIRM Apr avg: 1.00% median: -0.04% win: 40% σ: 7.87% n: 5 2022-04-12 → 2026-07-31 | MIRM May avg: -0.32% median: -1.64% win: 40% σ: 3.53% n: 5 2022-04-12 → 2026-07-31 | MIRM Jun avg: 10.78% median: 14.46% win: 60% σ: 22.00% n: 5 2022-04-12 → 2026-07-31 | MIRM Jul avg: 7.84% median: 1.55% win: 60% σ: 15.58% n: 5 2022-04-12 → 2026-07-31 | MIRM Aug avg: 12.84% median: 4.46% win: 75% σ: 20.25% n: 4 2022-04-12 → 2026-07-31 (current) | MIRM Sep avg: -1.66% median: -5.15% win: 25% σ: 15.45% n: 4 2022-04-12 → 2026-07-31 | MIRM Oct avg: -2.04% median: -1.14% win: 25% σ: 8.45% n: 4 2022-04-12 → 2026-07-31 | MIRM Nov avg: 5.09% median: 8.73% win: 75% σ: 17.22% n: 4 2022-04-12 → 2026-07-31 | MIRM Dec avg: -1.45% median: -1.70% win: 50% σ: 9.18% n: 4 2022-04-12 → 2026-07-31 |